The Heiarchy Of Cellular Adaptation Part 5

Now that we’ve worked through the hierarchy redox, mitochondrial membrane potential, energy sensing, and anabolic signaling it’s time to translate the model into real-world protocol design. The question isn’t just what to use, it’s when to use it, and in what order. This is where most people get stuck. They want to address everything at once, often stacking compounds that operate on different timelines, pathways, or levels of cellular readiness. But true adaptation doesn’t come from throwing the kitchen sink at the problem. It comes from layering the right signal at the right time.

Protocol design should be iterative, not fixed. You’re working with a dynamic system. The body is always reading inputs and recalibrating its response based on context. That’s why sequencing matters so much. You don’t open with growth signals if the redox environment is unstable. You don’t push fat oxidation if mitochondrial membrane potential is low. You don’t trigger autophagy with aggressive fasting if energy sensing is already impaired. You build the platform before you load the weight.

The first step in building a protocol is to assess the individual’s current state. Are they dealing with fatigue, poor recovery, inflammation, or cognitive fog? That usually points to redox dysfunction. Do they crash after exertion or feel wired but tired? That suggests instability in membrane potential. Are they stuck in a fat loss plateau despite perfect macros and training? That often reflects poor energy sensing. Are they training hard but not growing? That points to anabolic resistance due to upstream gating.

Once the entry point is clear, interventions should follow a “pull, stabilize, then push” rhythm. In the redox phase, you use compounds that enhance electron flow and reduce signaling noise things like mitochondrial-targeted antioxidants, plasmalogens, or ketone esters. The goal here is not to suppress oxidation, but to restore clarity in the cellular communication network. In the membrane potential phase, you introduce agents that stabilize the mitochondrial inner membrane—peptides like SS-31, structured lipids, or photobiomodulation. You don’t need a lot of input just consistency and a signal the cell can trust.

As Δψm stabilizes, you can begin to support energy sensing pathways—AMPK and mTOR—based on goals and feedback. This is where fasting, carb cycling, and metabolic modulators like 1-MNA or urolithin A have their place. But they must be used responsively. Not everyone needs to activate AMPK. And pushing it too hard in the wrong state will blunt recovery and growth. Likewise, feeding windows and mTOR-supportive strategies work best when energy signaling is coherent. Otherwise, you're building on a shaky foundation.

Only when those systems are aligned does it make sense to layer in anabolic drivers growth peptides, testosterone, IGF-1 analogs, and hypertrophy protocols. At this point, the signal will actually land. The tissues are ready. The receptors are primed. And the energy supply can support new tissue without compensating through inflammation or stress.

One of the most powerful features of this hierarchy is that it’s flexible. It doesn’t force a rigid protocol. It gives you a mapto navigate complexity. If someone isn’t progressing, instead of guessing or jumping to the next trendy compound, you go back down the ladder and ask: where did the system say no? Where did the signal get lost? Where did we skip a step?

This is how you shift from stack design to true protocol architecture. You're no longer just adding ingredients. You're managing adaptation layer by layer, with biological timing, mechanistic logic, and feedback-driven adjustments. This is how you build protocols that don’t just work on paper they work in real people, under real stress, in the real world.

9 comments